loader image
January 2023 Banner
COVID19 UPDATES
Slide
Slide
Slide 1
IEC
previous arrow
next arrow

Featured Activity

Featured Activity || On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran City, Bohol.

On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran...
Read More
Featured Activity || On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran City, Bohol.

Featured Activity || 18th NBW (DOH – FDA Healthcare Forum on Biotechnology)

On 21 – 25 November 2022, the annual celebration of the 18th National Biotechnology Week (NBW) pursuant to Proclamation No....
Read More
Featured Activity || 18th NBW (DOH – FDA Healthcare Forum on Biotechnology)

Featured Activity || Anti-Red Tape Authority (ARTA) “Streamlining and Digitalization of Government Processes in the Health Sector During and Beyond the Pandemic”

The Food and Drug Administration (FDA) participated in the health forum conducted by the Anti-Red Tape Authority (ARTA) with the...
Read More
Featured Activity || Anti-Red Tape Authority (ARTA) “Streamlining and Digitalization of Government Processes in the Health Sector During and Beyond the Pandemic”

Featured Activity || Philippine Antimicrobial Awareness Week

The Food and Drug Administration (FDA) participated in the Philippine Antimicrobial Awareness Week 2002 last Tuesday, November 22 at Seda...
Read More
Featured Activity || Philippine Antimicrobial Awareness Week

Featured Activity || The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth P300 million in a recent raid on nine (9) establishments in Bulacan.

The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth...
Read More
Featured Activity || The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth P300 million in a recent raid on nine (9) establishments in Bulacan.

Featured Activity || The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA) last Friday, October 7 at the Philippine International Convention Center.

The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA)...
Read More
Featured Activity || The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA) last Friday, October 7 at the Philippine International Convention Center.

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22 to 24 at the World Trade Center Metro Manila in Pasay City.

The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22...
Read More
Featured Activity || The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22 to 24 at the World Trade Center Metro Manila in Pasay City.

Featured Activity || The Philippine Association of Pharmacists in Veterinary Industry (PAPVI) pays a courtesy visit to the Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate.

  The Philippine Association of Pharmacists in Veterinary Industry (PAPVI) pays a courtesy visit to the Food and Drug Administration...
Read More
Featured Activity || The Philippine Association of Pharmacists in Veterinary Industry (PAPVI) pays a courtesy visit to the Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate.

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on 13-15 September.

The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on...
Read More
Featured Activity || The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on 13-15 September.

Featured Event

Featured Video

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

eServices Portal

New Online Application System for FDA Authorizations

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2023-0165 || INTEGRATION OF LANDBANK LINK.BIZPORTAL TO THE FDA ESERVICES PORTAL

The Food and Drug Administration (FDA), in its commitment to provide effective and efficient public health service delivery, has integrated...
Read More

FDA Advisory No.2023-0139 || Public Health Warning Against the Purchase and Use of the following Adulterated Cosmetic Products as Reported in the ASEAN Post-Marketing Alert System (PMAS):

The Food and Drug Administration (FDA) warns the public from purchasing and using the following adulterated cosmetic products which tested...
Read More

FDA Advisory No.2023-0163-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na “Xeomin 100 units powder for solution for injection Clostridium Botulinum neurotoxin type A (150kD). free from complexing proteins”

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng beripikadong pekeng gamot: Xeomin 100...
Read More

FDA Advisory No.2023-0164-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2023-0162-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2023-0164 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...
Read More

Announcement

Announcement || Implementation of the Food and Drug Administration (FDA) Eservices Portal System for the License to Operate (LTO) of Pest Control Operator (PCO) Establishments
The FDA hereby announces that the License to Operate (LTO) for Pest Control Operator (PCO) Establishments through the eServices Portal ...
Read More
FDA ORDER No.2022-1365-A || Lifting the Temporary Ban of Entry of Cured Pork Meat Products from Italy
In the interest of consistency and coherent efforts in preventing the entry of African Swine Fever Virus in the country, ...
Read More
GOOD DISTRIBUTION AND STORAGE PRACTICE FOR DRUG PRODUCTS (DRUGSTORES AND HOSPITAL PHARMACIES) GDSP-DS AND HP
The program will provide an introduction to Good Distribution and Storage Practice (GDSP) for Drugstores and Hospital Pharmacies and its ...
Read More

FDA on the News

FDA on the News || What’s inside the Food and Drug Administration? Watch and know more about FDA under its new leadership, Director General Samuel A. Zacate

Alam niyo ba na halos lahat ng kinokonsumo ng tao ay kailangan dumaan sa masusing pagsusuri ng Food and Drug...
Read More

FDA on the News || Giyera kontra counterfeit items, idineklara ng FDA Chief

Nagdeklara ang Food and Drug Administration ng war agaisnt counterfeit medicines. Ang pahayag ng FDA kasabay ng pagdiriwang ng National...
Read More

FDA on the News || Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng ‘National Consciousness Week Against Counterfeit Medicine.’

TINGNAN | Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng 'National Consciousness Week Against Counterfeit Medicine.' Kasalukuyang ginaganap...
Read More

FDA on the News || Food and Drug Administration (FDA) Harmonies graced the program In the Heart of Business by DWIZ 882 last Friday, November 11.

They performed their renditions of True Colors by Cyndi Lauper and "Pekeng Gamot," which was composed by Mr. Jonathan Sta....
Read More

Meet FDA Chief Eric Domingo, on COVID-19 response

READ HERE:  https://news.abs-cbn.com/ancx/culture/spotlight/01/17/21/which-covid-19-vaccine-does-the-filipino-deserve-its-up-to-this-guy-to-decide?fbclid=IwAR1k3zjxBwgS-9xpkCVaWM4bCbpI5TMvLWON2FCrLSOkzlqQ6Ws42AxZKXI
Read More

PH FDA QUALIFIES AS 5th ASEAN INSPECTION SERVICE

PH FDA QUALIFIES AS 5th ASEAN LISTED INSPECTION SERVICE - The Philippine Food and Drug Administration (FDA) has successfully qualified...
Read More

FDA Chief Orders Clean-Up Of Backlog

The Food and Drug Administration (FDA) is set to take drastic moves to address the backlog in the processing of...
Read More

FDA chief bats for early cancer detection

Food and Drug Administration (FDA) Director-General Nela Charade G. Puno last week called on women to have regular breast examinations,...
Read More

Press Statements

Press Release || The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro, Small, and Medium Enterprises) Program.

The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro,...
Read More

FDA Press Statement || Updates on the Voluntary Recall of Sangobion Kids Syrup

The Food and Drug Administration (FDA) issued FDA Advisory No. 2022-1968 on the voluntary recall of Iron + Vitamin B...
Read More

FDA STATEMENT || On Diethylene glycol and Ethylene glycol – contaminated Cough and Cold Syrup Manufactured by Maiden Pharmaceuticals, Ltd.

All pharmaceutical products, especially cough and cold syrups, that use glycerine as solvent, diluent, and thickening agent, are mandatorily required...
Read More

Press Statement || The Food and Drug Administration (FDA) Launches Taskforce Edward Which Aims to Make Safe and Effective COVID-19 Vaccines More Accessible to All Filipinos

Food and Drug Administration (FDA) Director General Dr. Samuel Zacate launches Taskforce Edward which has the primary objective to make...
Read More

FDA STATEMENT || ACTIONS RELATIVE TO THE EU-RASFF ALERT ON LUCKY ME! INSTANT NOODLE PRODUCTS MANUFACTURED IN THAILAND

The FDA received a copy of the European Union Rapid Alert System for Food and Feed (EU-RASFF) that Lucky Me!...
Read More

Press Release || FDA lauds SC decision upholding the agency’s regulatory authority over tobacco products 23 June 2022

The Food and Drug Administration (FDA) lauds the Supreme Court decision upholding the agency’s jurisdiction over tobacco products reaffirming the...
Read More

Press Statement || FDA Philippines Grants Emergency Use Authorization of CoronaVac (Sinovac) for Pediatric Group

On 11 March 2022, the Food and Drug Administration (FDA) granted the Emergency Use Authorization (EUA) of CoronaVac Vaccine, manufactured...
Read More

Press Release || FDA APPROVES SELF-ADMINISTERED COVID-19 ANTIGEN TEST KITS

The Food and Drug Administration (FDA) has approved two (2) self-administered COVID-19 antigen test kits in compliance with the application...
Read More

OFFICIAL STATEMENT OF THE FOOD AND DRUG ADMINISTRATION (FDA) ON THE ALLEGED IRREGULARITIES DURING INSPECTION AT MARKET REACH INTERNATIONAL RESOURCES, CORP.

08 June 2021 The FDA will fully cooperate with the NBI on the alleged irregularities during inspection at Market Reach...
Read More
Transparency-Seal

FOI

ISO

Citizens-Charter

GAD

Verification-Logo

Pharmacovigilance

Pharmacovigilance

Draft for Comments

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National or State of Public Health Emergencies

All comments may be sent at [email protected] The deadline for submission of comments is on 15 February 2023. I. RATIONALE In upholding...
Read More
Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National or State of Public Health Emergencies

Draft for Comments || Updated Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices

All comments may be sent at [email protected] The deadline for submission of comments is on 09 February 2023. I. BACKGROUND...
Read More
Draft for Comments || Updated Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices

Draft for Comments || Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.”

All comments may be sent at [email protected] The deadline for submission of comments is on 09 February 2023. I. RATIONALE On...
Read More
Draft for Comments || Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.”

Draft for Comments || Revised Guidelines on Food Additives and Processing Aids, Repealing Administrative Order 88-A s. 1984

You may submit your comments in MSWord format to [email protected] The deadline for submission of comments is on 03 February 2023. Draft for...
Read More
Draft for Comments || Revised Guidelines on Food Additives and Processing Aids, Repealing Administrative Order 88-A s. 1984

Draft for Comments || Guidelines on the Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) for Declaration of Nutrition Information on the Labels Repealing Bureau Circular No. 16 s. 2005 entitled “Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard”

You may submit your comments in MSWord format to [email protected] The deadline for submission of comments is on 02 February 2023. Draft for...
Read More
Draft for Comments || Guidelines on the Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) for Declaration of Nutrition Information on the Labels Repealing Bureau Circular No. 16 s. 2005 entitled “Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard”

Draft for Comments || Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration

All comments may be sent at [email protected] with the following Subject format: a. Comments_AO on Reliance for Regulatory Decision
Read More
Draft for Comments || Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health Emergencies

All comments may be sent at [email protected] with the following Subject format: a. Comments_AO on National Public Health Emergencies
Read More
Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health  Emergencies

Draft for Comments || Guidelines on Ethylene Oxide Residue Level in Raw Materials and Processed Prepackaged Food

You may submit your comments in MSWord format to [email protected] Cc [email protected] on or before 08 December 2022 using the...
Read More
Draft for Comments || Guidelines on Ethylene Oxide Residue Level in Raw Materials and Processed Prepackaged Food

Draft for Comments || Guidelines on the Conduct of Regulatory Inspections for Radiation Facilities

All comments and recommendations shall be sent to [email protected] I. BACKGROUND The Department of Health (DOH), through the issuance of...
Read More
Draft for Comments || Guidelines on the Conduct of Regulatory Inspections for Radiation Facilities

Draft for Comments || Amendment to Administrative Order No. 2020-0017 entitled, “Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003”

All comments may be sent at [email protected] The deadline for submission of comments is on 14 October 2022. I. RATIONALE...
Read More
Draft for Comments || Amendment to Administrative Order No. 2020-0017 entitled, “Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003”

Bids and Awards

NP-SVP(A)-2023-0003-AFS || Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemned Office Equipment/Records file for Safekeeping

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building...
Read More
NP-SVP(A)-2023-0003-AFS || Procurement of the Construction Materials for the  Renovation / Rehabilitation of FDA Annex Building  Basement for Storage of Unserviceable/Condemned  Office Equipment/Records file for Safekeeping

NP-SVP(A)-2022-0257-SLC || Procurement of Smart TV and Stand (Mobile)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Smart TV and Stand (Mobile)        
Read More
NP-SVP(A)-2022-0257-SLC || Procurement of Smart TV and Stand (Mobile)

NP-SVP(A)-2022-0258-ICTMD || Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located at CDRR

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located...
Read More
NP-SVP(A)-2022-0258-ICTMD || Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located at CDRR

NP-SVP(A)-2022-0256-AFS || Procurement of Memorabilia / Souvenir Items as Loyalty Incentives

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Memorabilia / Souvenir Items as Loyalty Incentives Technical Specification    
Read More
NP-SVP(A)-2022-0256-AFS || Procurement of Memorabilia / Souvenir Items as Loyalty Incentives

ITB No. 2022-0250-FROO-EPA || Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses, Cebu Testing and Quality Assurance Laboratory (CTQAL), and Davao Testing Quality Assurance Laboratory (DTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses,...
Read More
ITB No. 2022-0250-FROO-EPA || Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses, Cebu Testing and Quality Assurance Laboratory (CTQAL), and Davao Testing Quality Assurance Laboratory (DTQAL)

NP-SVP(A)-2022-0255-RFO-NCR || Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)      ...
Read More
NP-SVP(A)-2022-0255-RFO-NCR || Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)

NP-SHPG(A)-2022-0251-ICTMD || Procurement for the ICT Equipment

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the ICT Equipment    
Read More
NP-SHPG(A)-2022-0251-ICTMD || Procurement for the ICT Equipment

NP-SVP(A)-2022-0242-ATQAL || Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit Week Against Counterfeit Medicines

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit...
Read More
NP-SVP(A)-2022-0242-ATQAL || Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit Week Against Counterfeit Medicines

NP-SVP(A)-2022-0237-AFS || Procurement of Memorabilia/ Souvenir Items as Loyalty Incentives

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Memorabilia/ Souvenir Items as Loyalty Incentives Technical Specification        
Read More

NP-SVP(A)-2022-0241-AFS || Procurement for the Construction Materials for the Renovation/Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemed Office Equipment/Records file for Safekeeping

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Construction Materials for the Renovation/Rehabilitation of FDA Annex Building Basement for...
Read More
NP-SVP(A)-2022-0241-AFS || Procurement for the Construction Materials for the Renovation/Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemed Office Equipment/Records file for Safekeeping

Latest Issuances

Shares